๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies

โœ Scribed by Ben Jemaa, Awatef; Bouraoui, Yosra; Sallami, Sataa; Banasr, Ahmed; Rais, Nawfel; Ouertani, Latifa; Nouira, Yassin; Horchani, Ali; Oueslati, Ridha


Book ID
120194596
Publisher
BioMed Central
Year
2010
Tongue
English
Weight
709 KB
Volume
29
Category
Article
ISSN
1756-9966

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Comparison of serum prostate specific me
โœ Thomas H. Douglas; Ted O. Morgan; David G. McLeod; Judd W. Moul; Gerald P. Murph ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB ๐Ÿ‘ 1 views

ated with higher pathologic stage and grade in patients undergoing radical prostatectomy (RP). In earlier studies, serum prostate specific membrane antigen (PSMA)

Evaluation and comparison of two new pro
โœ Gerald P. Murphy; Robert J. Barren; Sheila J. Erickson; Victoria A. Bowes; Rober ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 816 KB

## BACKGROUND. Two new prostate cancer markers, free-prostate specific antigen (f-PSA) and prostate specific membrane antigen (PSMA) were recently introduced. This report summarizes a prospective two-year multicenter test of their diagnostic or prognostic capabilities. Total PSA was also measured.